Serum Cystatin C as a Potential Marker for Glomerular Filtration Rate in Patients with Cholangiocarcinoma

Autor: Mang Ngaih Ciin, Tanakorn Proungvitaya, Temduang Limpaiboon, Sittiruk Roytrakul, Ubon Cha’on, Doungdean Tummanatsakun, Siriporn Proungvitaya
Rok vydání: 2020
Předmět:
medicine.medical_specialty
030232 urology & nephrology
Renal function
urologic and male genital diseases
lcsh:RC254-282
Gastroenterology
Cholangiocarcinoma
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Chronic kidney disease epidemiology collaboration (CKD-EPI) equation
Serum cystatin
Internal medicine
parasitic diseases
medicine
In patient
Cystatin C
Stage (cooking)
reproductive and urinary physiology
Transplantation
Creatinine
biology
business.industry
Cancer
Hematology
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
medicine.disease
female genital diseases and pregnancy complications
CKD-EPI equation
Glomerular filtration rate

Oncology
chemistry
030220 oncology & carcinogenesis
biology.protein
Original Article
Glomerular filtration rate
business
Kidney disease
Zdroj: International Journal of Hematology-Oncology and Stem Cell Research
Scopus-Elsevier
International Journal of Hematology-Oncology and Stem Cell Research, Vol 14, Iss 3 (2020)
ISSN: 2008-2207
DOI: 10.18502/ijhoscr.v14i3.3723
Popis: Background: Cholangiocarcinoma (CCA) is the second most common primary hepatobiliary cancer. These patients have meager prognosis and short-term survival. Precise assessment of glomerular filtration rate is a fundamental aspect of clinical care in cancer patients. Cystatin C has been proposed to be superior to creatinine, a well-known marker of renal function. This study aimed to evaluate cystatin C as a marker of GFR calculation in CCA patients. Materials and Methods: One hundred thirty serum samples from CCA patients and 32 from controls were included in this study. Serum cystatin C was measured using immunoturbidity assay. Estimated glomerular filtration rate was calculated by three equations established by chronic kidney disease epidemiology collaboration (based on creatinine and/or cystatin C). Results: Serum cystatin C in CCA patients was higher than that of controls (p=0.0002). Cystatin C was positively correlated with BUN in CCA group (p=0.019). eGFR based on cystatin C and based on both cystatin C and creatinine in CCA was low with significantly different from those of control (p
Databáze: OpenAIRE